The findings come as both U.S. and EU drug safety regulators are conducting investigations into the potential risk of Ozempic suicide side effects users may face while using the diabetes and weight loss drugs.
The FDA has received more than 200 reports of suicide or suicidal ideations linked to widely used diabetes and weight loss drugs like Ozempic, Wegovy, Mounjaro and Zepbound.
The lawsuit claims Merck deceived regulators and the medical community during clinical trials designed to hide Gardasil HPV lawsuit injuries.
Child was diagnosed with lupus, anemia, abnormal weight loss and other autoimmune diseases after a Gardasil injection at age 11, requiring him to see specialists and undergo regular medical treatments.
The gastroparesis lawsuit claims the side effects of Ozempic and Mounjaro made the plaintiff vomit so much that her teeth are falling out.
Three cases of suicidal ideation have been reported in Iceland, all linked to Ozempic's active ingredient, semaglutide
Ozempic and Wegovy have been increasingly used by non-diabetics for weight loss in the U.S., raising concerns about the potential risks of thyroid cancer affecting a much larger portion of the population.
Some compounded versions of Ozempic and Wegovy use salt forms of the active ingredient which have not been tested or approved by the agency.
A leading hair loss expert warns that Ozempic problems may lead to androgenic alopecia, a progressive and permanent form of pattern baldness.
Some users say the Ozempic and Wegovy hair loss does not appear to be linked to weight loss caused by the diabetes drugs
